Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Hillside, NJ
SEC filing record 1 source field available
Fiscal year end
30 June
INTEGRATED BIOPHARMA INC has filed 552 SEC EDGAR filings since 21 Nov 1996

SEC filing history

Showing 126-150 of 282 matching filings.

Per page
25
Current page
6
4

PRIMARY DOCUMENT

Filing date
03 Nov 2021
Reporting date
03 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Nov 2021
Reporting date
03 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Nov 2021
Reporting date
03 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Nov 2021
Reporting date
03 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-31668

FORM DEF 14A

Filing date
27 Oct 2021
Reporting date
27 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31668

FORM 8-K

Filing date
02 Sep 2021
Reporting date
02 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31668

FORM 8-K

Filing date
07 Jul 2021
Reporting date
30 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31668

FORM 8-K

Filing date
13 May 2021
Reporting date
13 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31668

FORM 8-K

Filing date
08 Apr 2021
Reporting date
08 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31668

FORM 8-K

Filing date
12 Feb 2021
Reporting date
12 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31668

FORM 8-K

Filing date
22 Jan 2021
Reporting date
22 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31668

FORM 8-K

Filing date
30 Nov 2020
Reporting date
30 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Nov 2020
Reporting date
04 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Nov 2020
Reporting date
04 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Nov 2020
Reporting date
04 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Nov 2020
Reporting date
04 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Nov 2020
Reporting date
04 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Nov 2020
Reporting date
04 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Nov 2020
Reporting date
04 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Nov 2020
Reporting date
04 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
17 Nov 2020
Reporting date
04 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31668

FORM 8-K

Filing date
12 Nov 2020
Reporting date
12 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .